147 related articles for article (PubMed ID: 1489006)
1. Blood lactate is reduced following successful treatment of anaemia in haemodialysis patients with recombinant human erythropoietin both at rest and after maximal exertion.
Davenport A; Will EJ; Khanna SK; Davison AM
Am J Nephrol; 1992; 12(5):357-62. PubMed ID: 1489006
[TBL] [Abstract][Full Text] [Related]
2. Treatment of anaemia in haemodialysis patients with erythropoietin: long-term effects on exercise capacity.
Bárány P; Freyschuss U; Pettersson E; Bergström J
Clin Sci (Lond); 1993 Apr; 84(4):441-7. PubMed ID: 8482049
[TBL] [Abstract][Full Text] [Related]
3. The effect of erythropoietin on lactate, pyruvate and excess lactate under physical exercise in dialysis patients.
Meierhenrich R; Jedicke H; Voigt A; Lange H
Clin Nephrol; 1996 Feb; 45(2):90-7. PubMed ID: 8846536
[TBL] [Abstract][Full Text] [Related]
4. Effects of the correction of renal anaemia by erythropoietin on physiological changes during exercise.
Lewis NP; Macdougall IC; Willis N; Coles GA; Williams JD; Henderson AH
Eur J Clin Invest; 1993 Jul; 23(7):423-7. PubMed ID: 8375460
[TBL] [Abstract][Full Text] [Related]
5. Improved physical performance after treatment of renal anemia with recombinant human erythropoietin.
Braumann KM; Nonnast-Daniel B; Böning D; Böcker A; Frei U
Nephron; 1991; 58(2):129-34. PubMed ID: 1865966
[TBL] [Abstract][Full Text] [Related]
6. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.
BMJ; 1990 Mar; 300(6724):573-8. PubMed ID: 2108751
[TBL] [Abstract][Full Text] [Related]
7. Physical performance and associated electrolyte changes after haemoglobin normalization: a comparative study in haemodialysis patients.
McMahon LP; McKenna MJ; Sangkabutra T; Mason K; Sostaric S; Skinner SL; Burge C; Murphy B; Crankshaw D
Nephrol Dial Transplant; 1999 May; 14(5):1182-7. PubMed ID: 10344359
[TBL] [Abstract][Full Text] [Related]
8. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.
Winearls CG; Oliver DO; Pippard MJ; Reid C; Downing MR; Cotes PM
Lancet; 1986 Nov; 2(8517):1175-8. PubMed ID: 2877323
[TBL] [Abstract][Full Text] [Related]
9. Increased red cell 2,3-diphosphoglycerate levels in haemodialysis patients treated with erythropoietin.
Horina JH; Schwaberger G; Brussee H; Sauseng-Fellegger G; Holzer H; Krejs GJ
Nephrol Dial Transplant; 1993; 8(11):1219-22. PubMed ID: 8302459
[TBL] [Abstract][Full Text] [Related]
10. Human recombinant erythropoietin in anaemic patients on maintenance haemodialysis. Secondary effects of the increase of haemoglobin.
Zehnder C; Glück Z; Descoeudres C; Uehlinger DE; Blumberg A
Nephrol Dial Transplant; 1988; 3(5):657-60. PubMed ID: 3146724
[TBL] [Abstract][Full Text] [Related]
11. [Effect of recombinant human erythropoietin (rEPO) on angina pectoris in patients with chronic maintenance hemodialysis].
Imamura Y; Hase H
Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):403-8. PubMed ID: 1875559
[TBL] [Abstract][Full Text] [Related]
12. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of renal anemia with recombinant human erythropoietin].
Schaefer RM; Kürner B; Zech M; Krahn R; Heidland A
Dtsch Med Wochenschr; 1988 Jan; 113(4):125-9. PubMed ID: 3276487
[TBL] [Abstract][Full Text] [Related]
14. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F
Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
[TBL] [Abstract][Full Text] [Related]
15. Chapter 8 Haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2010: national and centre-specific analyses.
Webb L; Gilg J; Wilkie M
Nephron Clin Pract; 2012; 120 Suppl 1():c145-74. PubMed ID: 22964566
[TBL] [Abstract][Full Text] [Related]
16. Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients.
Robertson HT; Haley NR; Guthrie M; Cardenas D; Eschbach JW; Adamson JW
Am J Kidney Dis; 1990 Apr; 15(4):325-32. PubMed ID: 2321645
[TBL] [Abstract][Full Text] [Related]
17. Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin.
Macdougall IC; Lewis NP; Saunders MJ; Cochlin DL; Davies ME; Hutton RD; Fox KA; Coles GA; Williams JD
Lancet; 1990 Mar; 335(8688):489-93. PubMed ID: 1968526
[TBL] [Abstract][Full Text] [Related]
18. Treatment of anaemia resistant to conventional erythropoietin therapy with thymopentin in haemodialysis patients.
Raiola P; Manzo M; Saggese A; Tomasino G; Cicchella T; Rambaldi M; Pisano M; Lizza B; Perna AF
Nephrol Dial Transplant; 1995; 10 Suppl 6():48-50. PubMed ID: 8524495
[No Abstract] [Full Text] [Related]
19. [Recombinant human erythropoietin stimulates synthesis of fetal hemoglobin in patients with renal anemia treated by repeated hemodialysis].
Hanicki Z; Sułowicz W; Stepniewski M; Kuźniewski M; Kraśniak A; Kopeć J; Cieszkowska U; Solarska K
Pol Arch Med Wewn; 1991 Jun; 85(6):352-5. PubMed ID: 1716757
[TBL] [Abstract][Full Text] [Related]
20. Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients.
Goicoechea M; Vazquez MI; Ruiz MA; Gomez-Campdera F; Perez-García R; Valderrábano F
Nephron; 1998; 78(1):23-7. PubMed ID: 9453399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
